Corcept Therapeutics CORT Preferred Stock
Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockValueOutstanding.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's preferred stock.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's preferred stock?
- Corcept Therapeutics (CORT) reported preferred stock of $0 in Q1 2026.
- What does preferred stock mean?
- The value of special shares that have priority over common stock for dividends.
- How do you interpret preferred stock?
- An increase indicates the issuance of preferred equity for capital raising, while a decrease suggests redemption or conversion into common stock.
- How does preferred stock compare across companies?
- Standard equity metric; peers may or may not use preferred stock as part of their capital structure.